NCT03968991

VISIODOL: Validation of the VISIODOL® Scale

VISIODOL: Validation of the VISIODOL® Scale for Screening of Pain in People With Visual Impairment

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 37 (actual)
• Sponsor: University Hospital, Clermont-Ferrand · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The aim of this study is to validate the VISIODOL® scale for screening of pain in people with visual impairment.

Detailed description

The VISIODOL® monocentric study conducted at Clermont-Ferrand University Hospital is a cross-disciplinary diagnostic tool validation performed in patients with acquired or congenital visual impairment and healthy sighted volunteers. Different evaluations by thermal (Pathway Médoc®) and mechanical (electronic Von Frey®) tests will allow to compare the new VISIODOL® scale with the numerical scale, which is a commonly used tool. The ergonomic quality, the satisfaction of use and the quality of life, stress, anxiety and catastrophism of the patients will also be studied.

Conditions

• Visual Deficiency
• Congenital Blindness
• Acquired Blindness

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	VISIODOL® (Diagnostic tool)	Tool for assessing pain in the blind subject (with congenital or acquired deficiency)

Timeline

• Start date: 2019-06-18
• Primary completion: 2020-12-28
• Completion: 2020-12-28
• First posted: 2019-05-31
• Last updated: 2023-03-13

Locations

1 site across 1 country: France